title: A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
abstract: In a hypoglutamatergic rodent model, we have observed certain behaviours that might have relevance for the cognitive impairments seen in autism and schizophrenia. Thus, hypoglutamatergic mice show defective habituation, impaired attention, a meagre behavioural repertoire and a general behavioural primitivization. The aim of the present study was to characterise and quantify changes in movement pattern in mice rendered hypoglutamatergic by means of MK-801 treatment, using an automated video tracking system. Further, the effects of four different antipsychotic drugs, the classical neuroleptic haloperidol, the atypical antipsychotic clozapine, the DA D2/5-HT2A antagonist risperidone and the selective 5-HT2A-receptor antagonist M100907, were compared with respect to effects on NMDA antagonist-induced movement pattern alterations. We found that each receptor antagonist had a unique effect on the MK-801-induced behavioural primitivization. Haloperidol was unable to affect the monotonous behaviour induced by MK-801, while risperidone, clozapine and M100907 produced movement patterns of high intricacy.
authors.affiliation: Department of Pharmacology, Institute of Physiology and Pharmacology, Göteborg University, Sweden. marie.nilsson@pharm.gu.se
authors.forename: M
authors.initials: M
authors.lastname: Nilsson
authors.forename: S
authors.initials: S
authors.lastname: Waters
authors.forename: N
authors.initials: N
authors.lastname: Waters
authors.forename: A
authors.initials: A
authors.lastname: Carlsson
authors.forename: M L
authors.initials: ML
authors.lastname: Carlsson
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects* / Q000502:physiology*; D003024:Clozapine / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D005464:Fluorobenzenes / Q000494:pharmacology; D018698:Glutamic Acid / Q000172:deficiency*; D006220:Haloperidol / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D010880:Piperidines / Q000494:pharmacology; D018967:Risperidone / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists; D005464:Fluorobenzenes; D010880:Piperidines; D012702:Serotonin Antagonists; D018698:Glutamic Acid; D016291:Dizocilpine Maleate; C079049:volinanserin; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone